10Dec 2023
Babson Diagnostics Receives FDA Clearance for Key Component of Innovative BetterWay™ Blood Testing System

Babson Diagnostics Receives FDA Clearance for Key Component of Innovative BetterWay™ Blood Testing System

Babson Diagnostics™, a leading healthcare technology company, announced that a crucial component of its innovative BetterWay™ Blood Testing system has received 510(k) clearance from the U.S. Food and Drug Administration. This regulatory milestone paves the way for the imminent launch of BetterWay—a revolutionary blood testing service set to debut next year. BetterWay will transform blood testing by utilizing a minimal blood sample from a fingertip, ensuring convenience without compromising accuracy or test variety. Babson aims to address healthcare professional shortages and reduce costs, delivering an enhanced testing experience at accessible locations.

  • #family health

Like

Save

Share